Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke

Neuroscience

Volumn 166, Issue 1, 2010, Pages 252-262

  Garg, P ^a   Duncan, R S ^b   Kaja, S ^b   Koulen, P ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

ischemia; neurodegeneration; neuroprotection; receptors

Indexed keywords

CANNABINOID 1 RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; PALMIDROL; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; MALE; MOLECULAR MECHANICS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UPREGULATION;

ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; CYTOPROTECTION; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ETHANOLAMINES; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; STROKE; TREATMENT OUTCOME;

EID: 74449090257     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.11.069     Document Type: Article

References (56)

1. Berger C., Schmid P.C., Schabitz W.R., Wolf M., Schwab S., and Schmid H.H. Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?. J Neurochem 88 (2004) 1159-1167
2. Brusco A., Tagliaferro P., Saez T., and Onaivi E.S. Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 62 (2008) 944-949
3. Brusco A., Tagliaferro P.A., Saez T., and Onaivi E.S. Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. Ann N Y Acad Sci 1139 (2008) 450-457
4. Calabresi P., Cupini L.M., Centonze D., Pisani F., and Bernardi G. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann Neurol 53 (2003) 693-702
5. Chang H.T., Huang C.C., Cheng H.H., Wang J.L., Lin K.L., Hsu P.T., Tsai J.Y., Liao W.C., Lu Y.C., Huang J.K., and Jan C.R. Mechanisms of AM404-induced [Ca(2+)] (i) rise and death in human osteosarcoma cells. Toxicol Lett 179 (2008) 53-58
6. Crack P.J., and Taylor J.M. Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 38 (2005) 1433-1444
7. De Petrocellis L., Davis J.B., and Di Marzo V. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett 506 (2001) 253-256
8. Di Marzo V., De Petrocellis L., Fezza F., Ligresti A., and Bisogno T. Anandamide receptors. Prostaglandins, Leukotrienes and Essential Fatty Acids 66 (2002) 377-391
9. Epps D.E., Natarajan V., Schmid P.C., and Schmid H.O. Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium. Biochim Biophys Acta 618 (1980) 420-430
10. Epps D.E., Schmid P.C., Natarajan V., and Schmid H.H. N-Acylethanolamine accumulation in infarcted myocardium. Biochem Biophys Res Commun 90 (1979) 628-633
11. Fraser C.C. Exploring the positive and negative consequences of NF-kappaB inhibition for the treatment of human disease. Cell Cycle 5 (2006) 1160-1163
12. Fride E. Endocannabinoids in the central nervous system-an overview. Prostaglandins Leukot Essent Fatty Acids 66 (2002) 221-233
13. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., and Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232 (1995) 54-61
14. Gibson C.L., Gray L.J., Murphy S.P., and Bath P.M. Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab 26 (2006) 1103-1113
15. Green A.R., and Ashwood T. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers. Curr Drug Targets CNS Neurol Disord 4 2 (2005) 109-118
16. Hu X.M., Zhang Y., and Zeng F.D. Effects of beta-aescin on apoptosis induced by transient focal cerebral ischemia in rats. Acta Pharmacol Sin 25 (2004) 1267-1275
17. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., and Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265 (1994) 1883-1885
18. Iadecola C., and Gorelick P.B. The Janus face of cyclooxygenase-2 in ischemic stroke: shifting toward downstream targets. Stroke 36 (2005) 182-185
19. Jonsson K.O., Vandevoorde S., Lambert D.M., Tiger G., and Fowler C.J. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br J Pharmacol 133 (2001) 1263-1275
20. Kim S.H., Won S.J., Mao X.O., Jin K., and Greenberg D.A. Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury. J Pharmacol Exp Ther 313 (2005) 88-94
21. Kim S.H., Won S.J., Mao X.O., Jin K., and Greenberg D.A. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity. Mol Pharmacol 69 (2006) 691-696
22. Koulen P., and Chapman K. Modulation of intracellular calcium signaling by N-acylethanolamines (2006) US patent publication number 2006-0142395 A1
23. Lambert D.M., and Di Marzo V. The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic?. Curr Med Chem 6 (1999) 757-773
24. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B., Flegal K., Ford E., Furie K., Go A., Greenlund K., Haase N., Hailpern S., Ho M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M., Meigs J., Mozaffarian D., Nichol G., O'Donnell C., Roger V., Rosamond W., Sacco R., Sorlie P., Stafford R., Steinberger J., Thom T., Wasserthiel-Smoller S., Wong N., Wylie-Rosett J., and Hong Y. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119 (2009) 480-486
25. Lo E.H., Dalkara T., and Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4 (2003) 399-415
26. Maccarrone M., Lorenzon T., Bari M., Melino G., and Finazzi-Agro A. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem 275 (2000) 31938-31945
27. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutierrez S.O., van der Stelt M., Lopez-Rodriguez M.L., Casanova E., Schutz G., Zieglgansberger W., Di Marzo V., Behl C., and Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
28. Mattson M.P. NF-kappaB in the survival and plasticity of neurons. Neurochem Res 30 (2005) 883-893
29. Moesgaard B., Jaroszewski J.W., and Hansen H.S. Accumulation of N-acyl-ethanolamine phospholipids in rat brains during post-decapitative ischemia: a 31p NMR study. J Lipid Res 40 (1999) 515-521
30. Moesgaard B., Petersen G., Jaroszewski J.W., and Hansen H.S. Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain. A (31)P NMR and enzyme activity study. J Lipid Res 41 (2000) 985-990
31. Moro M.A., Cardenas A., Hurtado O., Leza J.C., and Lizasoain I. Role of nitric oxide after brain ischaemia. Cell Calcium 36 (2004) 265-275
32. Natarajan V., Schmid P.C., and Schmid H.H. N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain. Biochim Biophys Acta 878 (1986) 32-41
33. Nichols T.C. NF-kappaB and reperfusion injury. Drug News Perspect 17 (2004) 99-104
34. Nijboer C.H., Heijnen C.J., Groenendaal F., May M.J., van Bel F., and Kavelaars A. Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 39 (2008) 2129-2137
35. Perez-Asensio F.J., Hurtado O., Burguete M.C., Moro M.A., Salom J.B., Lizasoain I., Torregrosa G., Leza J.C., Alborch E., Castillo J., Knowles R.G., and Lorenzo P. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia. Neurobiol Dis 18 (2005) 375-384
36. Schabitz W.R., Giuffrida A., Berger C., Aschoff A., Schwaninger M., Schwab S., and Piomelli D. Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Stroke 33 (2002) 2112-2114
37. Schatz A.R., Lee M., Condie R.B., Pulaski J.T., and Kaminski N.E. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 142 (1997) 278-287
38. Schomacher M., Muller H.D., and Sommer C. Short-term ischemia usually used for ischemic preconditioning down-regulates central cannabinoid receptors in the gerbil hippocampus. Acta Neuropathol 111 (2006) 8-14
39. Schomacher M., Muller H.D., Sommer C., Schwab S., and Schabitz W.R. Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia. Brain Res 1240 (2008) 213-220
40. Sheehan J.J., and Tsirka S.E. Fibrin-modifying serine proteases thrombin, tPA, and plasmin in ischemic stroke: a review. Glia 50 (2005) 340-350
41. Shirakawa H., Yamaoka T., Sanpei K., Sasaoka H., Nakagawa T., and Kaneko S. TRPV1 stimulation triggers apoptotic cell death of rat cortical neurons. Biochem Biophys Res Commun 377 (2008) 1211-1215
42. Shouman B., Fontaine R.H., Baud O., Schwendimann L., Keller M., Spedding M., Lelievre V., and Gressens P. Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage. Br J Pharmacol 148 (2006) 442-451
43. Sinor A.D., Irvin S.M., and Greenberg D.A. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci Lett 278 (2000) 157-160
44. Smart D., Jonsson K.O., Vandevoorde S., Lambert D.M., and Fowler C.J. 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br J Pharmacol 136 (2002) 452-458
45. Sommer C., Schomacher M., Berger C., Kuhnert K., Muller H.D., Schwab S., and Schabitz W.R. Neuroprotective cannabinoid receptor antagonist SR 141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra. Acta Neuropathol 112 (2006) 277-286
46. Stokely M.E., Garg P., Bhat M.A., and Koulen P. Transient 5-(4-phenylbutoxy)psoralen (PAP-1) treatment dissociates developing pathologies in autoimmune optic neuritis into two distinct pathology profiles. J Neurosci Res 86 (2008) 2111-2124
47. Sugiura T., Kondo S., Kishimoto S., Miyashita T., Nakane S., Kodaka T., Suhara Y., Takayama H., and Waku K. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J Biol Chem 275 (2000) 605-612
48. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., and Sharp F.R. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10 (1990) 290-293
49. Tsubokawa T., Jadhav V., Solaroglu I., Shiokawa Y., Konishi Y., and Zhang J.H. Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Stroke 38 (2007) 1057-1062
50. Wen Y., Onyewuchi O., Yang S., Liu R., and Simpkins J.W. Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res 1009 (2004) 1-8
51. Wen Y., Yang S., Liu R., Perez E., Yi K.D., Koulen P., and Simpkins J.W. Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res 1008 (2004) 147-154
52. Wen Y., Yang S.H., Liu R., Perez E.J., Brun-Zinkernagel A.M., Koulen P., and Simpkins J.W. Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta 1772 (2007) 473-483
53. White B.C., Sullivan J.M., DeGracia D.J., O'Neil B.J., Neumar R.W., Grossman L.I., Rafols J.A., and Krause G.S. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179 (2000) 1-33
54. Xu J., Culman J., Blume A., Brecht S., and Gohlke P. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke 34 (2003) 1287-1292
55. Yenari M.A., and Han H.S. Influence of hypothermia on post-ischemic inflammation: role of nuclear factor kappa B (NFkappaB). Neurochem Int 49 (2006) 164-169
56. Zygmunt P.M., Chuang H., Movahed P., Julius D., and Hogestatt E.D. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 396 (2000) 39-42